ArticleJournal of pharmacopuncture2026
GC-MS-Based Quantification and Chemometric Discrimination of Multi-Marker Profiles in Carthami Flos-Based Pharmacopuncture Formulations.
Article in Journal of pharmacopuncture, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Pharmacopuncture is widely used in traditional Korean medicine, but its clinical reliability depends on chemical consistency and quality assessment. The present study aimed to establish a quantitative approach using gas chromatography-mass spectrometry (GC-MS) for simultaneously identifying and profiling key fatty acid marker compounds in Carthami Flos (CF) and Carthami Flos combined with deer antler (CFC) formulations. Whether this approach could be used in comparative quality evaluation was also evaluated. Methods: The GC-MS method was used to quantify four fatty acids (palmitic acid, stearic acid, oleic acid, and linoleic acid) in CF and CFC formulations. Analytes were identified based on retention times and characteristic electrospray ionization mass spectral fragment ions. The analysis was conducted in the selective ion monitoring (SIM) mode to enhance analytical selectivity and sensitivity, particularly for structurally similar fatty acids. Univariate analysis and principal component analysis (PCA) were performed. Results: All four fatty acids were consistently detected and unambiguously identified in both CF and CFC formulations under the optimized GC-MS conditions. The SIM mode enabled the selective differentiation and accurate quantification of structurally similar fatty acids. Linoleic acid was the most abundant component in both formulations. Univariate analysis revealed a significant difference only in oleic acid content, but PCA discriminated CF and CFC samples, with the first two principal components explaining 97.56% of the total variance. Conclusion: The GC-MS-based multi-marker profiling seems feasible for quantitative comparison and PCA-based discrimination of CF and CFC pharmacopuncture formulations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.